BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9228472)

  • 41. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
    Colombo AL
    Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.
    Puig-Asensio M; Fernández-Ruiz M; Aguado JM; Merino P; Lora-Pablos D; Guinea J; Martín-Dávila P; Cuenca-Estrella M; Almirante B
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3291-300. PubMed ID: 26976872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
    Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE
    Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
    Le A; Farmakiotis D; Tarrand JJ; Kontoyiannis DP
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problems and controversies in the management of hematogenous candidiasis.
    Uzun O; Anaissie EJ
    Clin Infect Dis; 1996 May; 22 Suppl 2():S95-101. PubMed ID: 8722835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.
    Pachl J; Svoboda P; Jacobs F; Vandewoude K; van der Hoven B; Spronk P; Masterson G; Malbrain M; Aoun M; Garbino J; Takala J; Drgona L; Burnie J; Matthews R;
    Clin Infect Dis; 2006 May; 42(10):1404-13. PubMed ID: 16619152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
    Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
    Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
    Edwards JE; Filler SG
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S106-13. PubMed ID: 1562680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
    Malik IA; Moid I; Aziz Z; Khan S; Suleman M
    Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
    Wilson AG; Micek ST; Ritchie DJ
    Clin Ther; 2005 Aug; 27(8):1228-37. PubMed ID: 16199247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines.
    Garey KW; Pai MP; Suda KJ; Turpin RS; Rege MD; Mingo DE; Bearden DT
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):919-27. PubMed ID: 17286303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Candidemia in elderly people: apropos of 4 cases].
    Kaltenbach G; Vogel T; Noblet-Dick M; Heitz D; Berthel M; Kuntzmann F
    Rev Med Interne; 2002 Mar; 23(3):328-31. PubMed ID: 11928382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B].
    Saitoh T; Matsushima T; Shimizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
    Rinsho Ketsueki; 2008 Feb; 49(2):94-8. PubMed ID: 18341039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candidemia: a nosocomial complication in adults with late-stage AIDS.
    Launay O; Lortholary O; Bouges-Michel C; Jarrousse B; Bentata M; Guillevin L
    Clin Infect Dis; 1998 May; 26(5):1134-41. PubMed ID: 9597242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
    Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
    Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients.
    Lake DE; Kunzweiler J; Beer M; Buell DN; Islam MZ
    Chemotherapy; 1996; 42(4):308-14. PubMed ID: 8804799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.